About Acobiom
Acobiom is a Healthcare company based in Grabels (France) founded in 1999 by David Piquemal and Didier Ritter. It operates as a diagnostics for personalized medicine and omics services are developed. Its chief executive is Didier Ritter. Acobiom offers products and services including GemciTest, Omics Services, RNA-Seq, and qPCR. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Gastrointestinal Cancer. Its competitors include DermTech, NeuMoDx, Biomeme, Molbio Diagnostics and Kryptos Biotechnologies and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
Acobiom was founded in 1999 in Grabels, France, focusing on biotechnology. Diagnostics and companion diagnostics are developed and commercialized by the company for personalized medicine in areas such as cancer and neurodegenerative diseases. Omics services are also provided for research and clinical trials. Operations center on advancing precision diagnostics within the European biotech sector.
- Headquarters Grabels, France
- Founders David Piquemal, Didier Ritter
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website acobiom.com/en
- Social LinkedIn X Facebook
- Latest Funding Round$60.68K (USD), Grant
Jan 2021
- InvestorsBpifrance
& 2 more
Products & Services of Acobiom
Acobiom offers a comprehensive portfolio of products and services, including GemciTest, Omics Services, RNA-Seq, and qPCR.
Predicts patient response to Gemcitabine in pancreatic cancer treatment.
Offers sequencing and bioinformatics for translational medicine research.
Performs RNA sequencing analyses for biomarker discovery.
Enables quantitative PCR for gene expression studies.
Funding Insights of Acobiom
- Total Rounds 5
- Last Round Grant — $60,681
- First Round $1.29M
(Sep 2013)
- Investors Count 3
All 5 funding rounds of Acobiom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $60,681 | Grant | – | – | |
| Dec 2019 | $55,095 | Grant | – | – | |
| Apr 2018 | $27,704 | Grant | – | – | |
| Jan 2018 | $660,599 | Grant | – | – | |
| Sep 2013 | $1.29M | Unspecified | – | – |
3 investors in total: 3 institutional.
Investors in Acobiom
Acobiom has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France |
Investor details for Acobiom
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Acobiom
2 people are tracked at Acobiom (2 in leadership).
| Name | Role | Group |
|---|---|---|
David Piquemal | Co-Founder & CSO | Leadership |
Didier Ritter | Co-Founder & CEO | Leadership |
Complete people profiles for Acobiom
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Acobiom
3 dated milestones of Acobiom across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Acobiom is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Grant, of $61K.
Competitors of Acobiom
Acobiom has 10 listed competitors in our database, 10 of them funded. They include DermTech, NeuMoDx, Biomeme, Molbio Diagnostics and Kryptos Biotechnologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dermtech.com | 1996 | San Diego, United States | $24.37M | 259 | Adhesive patch biopsies for skin cancer detection are provided. | |
| neumodx.com | 2012 | Ann Arbor, United States | $66.04M | 125 | Developer of a platform for low cost molecular testing | |
| biomeme.com | 2013 | Philadelphia, United States | $6.2M | 202 | Smartphone-based DNA detection platform is developed for diagnostics. | |
| molbiodiagnostics.com | 2000 | Salcete, India | $123.98M | 714 | Point-of-care molecular platforms for infectious disease detection are developed. | |
| kryptosbio.com | 2017 | Hayward, United States | $12.7M | – | Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology. | |
| quantalife.com | 2008 | Pleasanton, United States | $28.71M | – | Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. | |
| altratech.com | 2013 | Clarecastle, Ireland | $10.98M | – | Next-generation molecular detection kits for viral diseases are developed. | |
| targetingone.com | 2015 | Haidian, China | $23.19M | – | Micro-droplet digital PCR and diagnostic reagents are manufactured. | |
| amplifiedsciences.com | 2016 | West Lafayette, United States | $6.18M | – | Developer of in-vitro diagnostic assays for early detection of pancreatic cancer | |
| spindiag.de | 2016 | – | $27.69M | – | Point-of-care systems for screening drug-resistant pathogens are developed. |
Detailed competitors of Acobiom
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Acobiom
The website of Acobiom (acobiom.com) receives about 3.5K visits a month.
- Monthly visits3.5K
▲ 15.3% vs previous month
Websites whose visitors overlap most with Acobiom. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
centre-hepato-biliaire.org | centre-hepato-biliaire.org | 100% | – | #815,990 | – |
lecancer.fr | lecancer.fr | 99% | – | #3,154,369 | – |
canceropole-clara.com | canceropole-clara.com | 88% | – | #10,730,336 | – |
| gustaveroussy.fr | 87% | 323.6K | #128,815 | View details | |
| fondation-arc.org | 87% | 125.8K | #292,933 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Acobiom
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Acobiom (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Acobiom
Acobiom was founded in 1999 and raised its 1st funding round 14 years after it was founded.
Acobiom is headquartered in Grabels, France. It is registered at Grabels, Herault, France.
Didier Ritter is the current CEO of Acobiom. They have also founded this company.
Acobiom was founded in 1999 in Grabels, France, focusing on biotechnology. Diagnostics and companion diagnostics are developed and commercialized by the company for personalized medicine in areas such as cancer and neurodegenerative diseases. Omics services are also provided for research and clinical trials. Operations center on advancing precision diagnostics within the European biotech sector.
Acobiom's top competitors include DermTech, Molbio Diagnostics and NeuMoDx.
Acobiom offers GemciTest, Omics Services, RNA-Seq, and qPCR.
Acobiom has 3 investors. Key investors include Bpifrance, European Union, and EIC Fund.